Antidiabetic Potential of Novel 1,3,5-Trisubstituted-2-Thioxoimidazloidin-4-One Analogues: Insights into α-Glucosidase, α-Amylase, and Antioxidant Activities

As the ninth leading cause of death globally, diabetes mellitus (DM) is considered to be the worst chronic metabolic disease requiring an enormous need for healthcare with over 578 million expected cases by 2023. Several recent findings have demonstrated that mediating the activity of carbohydrate-h...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Salma M. Khirallah, Heba M. M. Ramadan, Hossam Aladl Aladl Aladl, Najla O. Ayaz, Lina A. F. Kurdi, Mariusz Jaremko, Samar Zuhair Alshawwa, Essa M. Saied
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-12-01
coleção:	Pharmaceuticals
Assuntos:	substituted-2-thiohydantoins diabetes mellitus antidiabetic activity α-glucosidase activity α-amylase activity cytotoxicity
Acesso em linha:	https://www.mdpi.com/1424-8247/15/12/1576
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!